CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and Femara (letrozole) can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will al...
Phase 2
Houston, Texas, United States and 1 other location
To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer...
Phase 1
Houston, Texas, United States
The primary objectives of this study are to compare sacituzumab tirumotecan to Treatment of Physician's Choice (TPC) with respect to progression-free...
Phase 3
Houston, Texas, United States and 71 other locations
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Shenandoah, Texas, United States and 66 other locations
To learn if the combination of DKN-01 and pembrolizumab can help to control advanced or recurrent endometrial cancer....
Phase 2
Houston, Texas, United States
IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...
Phase 1
Houston, Texas, United States and 5 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Houston, Texas, United States and 202 other locations
compared to Tamoxifen and Medroxyprogesterone acetate in treating endometrial cancer and to determine the types and severity of sid...
Phase 2
Houston, Texas, United States and 25 other locations
and metformin can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will also be stu...
Phase 2
Houston, Texas, United States and 5 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Houston, Texas, United States and 75 other locations
Clinical trials
Research sites
Resources
Legal